US Equity
SLS
— SELLAS LIFE SCIENCES GROUP, INC.SELLAS Life Sciences Group, Inc. is a clinical-stage biopharmaceutical company developing cancer immunotherapy treatments.
💰 Market cap: $2.13B📍 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036 US🏷️ Biotechnology & Medical Research💵 Previous close: $11.32🔢 5,806 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $11.32 |
| 2026-07-23 | $12.34 |
| 2026-07-22 | $12.08 |
| 2026-07-21 | $12.90 |
| 2026-07-20 | $12.47 |
| 2026-07-17 | $13.19 |
| 2026-07-16 | $11.75 |
| 2026-07-15 | $12.79 |
| 2026-07-14 | $13.39 |
| 2026-07-13 | $12.62 |
| 2026-07-10 | $12.76 |
| 2026-07-09 | $13.51 |
| 2026-07-08 | $13.76 |
| 2026-07-07 | $13.50 |
| 2026-07-06 | $13.94 |
| 2026-07-02 | $14.98 |
| 2026-07-01 | $13.27 |
| 2026-06-30 | $14.76 |
| 2026-06-29 | $15.45 |
| 2026-06-26 | $12.39 |
| 2026-06-25 | $10.53 |
| 2026-06-24 | $9.17 |
| 2026-06-23 | $9.07 |
| 2026-06-22 | $8.53 |
| 2026-06-18 | $8.05 |
| 2026-06-17 | $7.76 |
| 2026-06-16 | $7.53 |
| 2026-06-15 | $7.73 |
| 2026-06-12 | $7.83 |
| 2026-06-11 | $7.75 |
| 2026-06-10 | $7.15 |
| 2026-06-09 | $7.68 |
| 2026-06-08 | $7.98 |
| 2026-06-05 | $8.23 |
| 2026-06-04 | $9.04 |
| 2026-06-03 | $8.19 |
| 2026-06-02 | $8.33 |
| 2026-06-01 | $9.07 |
| 2026-05-29 | $9.31 |
| 2026-05-28 | $9.18 |
| 2026-05-27 | $8.58 |
| 2026-05-26 | $8.12 |
| 2026-05-22 | $7.78 |
| 2026-05-21 | $7.56 |
| 2026-05-20 | $8.97 |
| 2026-05-19 | $7.59 |
| 2026-05-18 | $7.29 |
| 2026-05-15 | $7.08 |
| 2026-05-14 | $7.42 |
| 2026-05-13 | $6.53 |
| 2026-05-12 | $5.22 |
| 2026-05-11 | $5.25 |
| 2026-05-08 | $5.01 |
| 2026-05-07 | $4.93 |
| 2026-05-06 | $5.15 |
| 2026-05-05 | $4.87 |
| 2026-05-04 | $5.02 |
| 2026-05-01 | $4.93 |
| 2026-04-30 | $4.95 |
| 2026-04-29 | $4.67 |
| 2026-04-28 | $4.88 |